- Home
- MOD vs ROIV Comparison
MOD vs ROIV Comparison
Compare MOD & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOD
- ROIV
- Stock Information
- Founded
- MOD 1916
- ROIV 2014
- Country
- MOD United States
- ROIV United Kingdom
- Employees
- MOD N/A
- ROIV N/A
- Industry
- MOD Auto Parts:O.E.M.
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- MOD Consumer Discretionary
- ROIV Health Care
- Exchange
- MOD Nasdaq
- ROIV Nasdaq
- Market Cap
- MOD 8.2B
- ROIV 8.6B
- IPO Year
- MOD N/A
- ROIV N/A
- Fundamental
- Price
- MOD $153.37
- ROIV $19.94
- Analyst Decision
- MOD Strong Buy
- ROIV Strong Buy
- Analyst Count
- MOD 4
- ROIV 8
- Target Price
- MOD $178.75
- ROIV $21.06
- AVG Volume (30 Days)
- MOD 953.0K
- ROIV 8.1M
- Earning Date
- MOD 10-28-2025
- ROIV 11-10-2025
- Dividend Yield
- MOD N/A
- ROIV N/A
- EPS Growth
- MOD 14.04
- ROIV N/A
- EPS
- MOD 3.47
- ROIV N/A
- Revenue
- MOD $2,685,700,000.00
- ROIV $23,233,000.00
- Revenue This Year
- MOD $18.91
- ROIV N/A
- Revenue Next Year
- MOD $15.23
- ROIV $320.50
- P/E Ratio
- MOD $42.12
- ROIV N/A
- Revenue Growth
- MOD 8.10
- ROIV N/A
- 52 Week Low
- MOD $64.79
- ROIV $8.73
- 52 Week High
- MOD $166.94
- ROIV $20.09
- Technical
- Relative Strength Index (RSI)
- MOD 49.78
- ROIV 77.99
- Support Level
- MOD $144.51
- ROIV $19.30
- Resistance Level
- MOD $157.99
- ROIV $20.09
- Average True Range (ATR)
- MOD 8.68
- ROIV 0.57
- MACD
- MOD -1.33
- ROIV 0.08
- Stochastic Oscillator
- MOD 42.38
- ROIV 90.39
About MOD Modine Manufacturing Company
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.